|
1
|
Dirnagl U: Pathobiology of injury after
stroke: The neurovascular unit and beyond. Ann N Y Acad Sci.
1268:21–25. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gu Y, Chen J and Shen J: Herbal medicines
for ischemic stroke: Combating inflammation as therapeutic targets.
J Neuroimmune Pharmacol. 9:313–339. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lucas K and Maes M: Role of the toll like
receptor (TLR) radical cycle in chronic inflammation: Possible
treatments targeting the TLR4 pathway. Mol Neurobiol. 48:190–204.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tu XK, Yang WZ, Shi SS, Wang CH, Zhang GL,
Ni TR, Chen CM, Wang R, Jia JW and Song QM: Spatio-temporal
distribution of inflammatory reaction and expression of TLR2/4
signaling pathway in rat brain following permanent focal cerebral
ischemia. Neurochem Res. 35:1147–1155. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Caso JR, Pradillo JM, Hurtado O, Lorenzo
P, Moro MA and Lizasoain I: Toll-like receptor 4 is involved in
brain damage and inflammation after experimental stroke.
Circulation. 115:1599–1608. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tu XK, Yang WZ, Shi SS, Chen Y, Wang CH,
Chen CM and Chen Z: Baicalin inhibits TLR2/4 signaling pathway in
rat brain following permanent cerebral ischemia. Inflammation.
34:463–470. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guan T, Liu Q, Qian Y, Yang H, Kong J, Kou
J and Yu B: Ruscogenin reduces cerebral ischemic injury via
NF-κB-mediated inflammatory pathway in the mouse model of
experimental stroke. Eur J Pharmacol. 714:303–311. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lan L, Tao J, Chen A, Xie G, Huang J, Lin
J, Peng J and Chen L: Electroacupuncture exerts anti-inflammatory
effects in cerebral ischemia-reperfusion injured rats via
suppression of the TLR4/NF-κB pathway. Int J Mol Med. 31:75–80.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mokni M, Hamlaoui S, Karkouch I, Amri M,
Marzouki L, Limam F and Aouani E: Resveratrol provides
cardioprotection after ischemia/reperfusion injury via modulation
of antioxidant enzyme activities. Iran J Pharm Res. 12:867–875.
2013.PubMed/NCBI
|
|
10
|
Kma L: Synergistic effect of resveratrol
and radiotherapy in control of cancers. Asian Pac J Cancer Prev.
14:6197–6208. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Taguchi A, Wada-Hiraike O, Kawana K, Koga
K, Yamashita A, Shirane A, Urata Y, Kozuma S, Osuga Y and Fujii T:
Resveratrol suppresses inflammatory responses in endometrial
stromal cells derived from endometriosis: A possible role of the
sirtuin 1 pathway. J Obstet Gynaecol Res. 40:770–778. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou XM, Zhou ML, Zhang XS, Zhuang Z, Li
T, Shi JX and Zhang X: Resveratrol prevents neuronal apoptosis in
an early brain injury model. J Surg Res. 189:159–165. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ren J, Fan C, Chen N, Huang J and Yang Q:
Resveratrol pretreatment attenuates cerebral ischemic injury by
upregulating expression of transcription factor Nrf2 and HO-1 in
rats. Neurochem Res. 36:2352–2362. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shi SS, Yang WZ, Tu XK, Wang CH, Chen CM
and Chen Y: 5-Lipoxygenase inhibitor zileuton inhibits neuronal
apoptosis following focal cerebral ischemia. Inflammation.
36:1209–1217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bederson JB, Pitts LH, Tsuji M, Nishimura
MC, Davis RL and Bartkowski H: Rat middle cerebral artery
occlusion: Evaluation of the model and development of a neurologic
examination. Stroke. 17:472–476. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen F, Qi Z, Luo Y, Hinchliffe T, Ding G,
Xia Y and Ji X: Non-pharmaceutical therapies for stroke: Mechanisms
and clinical implications. Prog Neurobiol. 115:246–269. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Salam KA, Ummer K, Pradeep Kumar VG and
Noone ML: Intravenous thrombolysis for acute ischemic stroke in the
3 to 4.5-hour window-The Malabar experience. Int J Stroke.
9:426–428. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bansal S, Sangha KS and Khatri P: Drug
treatment of acute ischemic stroke. Am J Cardiovasc Drugs.
13:57–69. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pan J, Konstas AA, Bateman B, Ortolano GA
and Pile-Spellman J: Reperfusion injury following cerebral
ischemia: Pathophysiology, MR imaging, and potential therapies.
Neuroradiology. 49:93–102. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu KT, Chiou RY, Chen LG, Chen MH, Tseng
WT, Hsieh HT and Yang YL: Neuroprotective effects of resveratrol on
cerebral ischemia-induced neuron loss mediated by free radical
scavenging and cerebral blood flow elevation. J Agric Food Chem.
54:3126–3131. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sinha K, Chaudhary G and Gupta YK:
Protective effect of resveratrol against oxidative stress in middle
cerebral artery occlusion model of stroke in rats. Life Sci.
71:655–665. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsai SK, Hung LM, Fu YT, Cheng H, Nien MW,
Liu HY, Zhang FB and Huang SS: Resveratrol neuroprotective effects
during focal cerebral ischemia injury via nitric oxide mechanism in
rats. J Vasc Surg. 46:346–353. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Z, Pang L, Fang F, Zhang G, Zhang J,
Xie M and Wang L: Resveratrol attenuates brain damage in a rat
model of focal cerebral ischemia via up-regulation of hippocampal
Bcl-2. Brain Res. 1450:116–124. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Orsu P, Murthy BV and Akula A:
Cerebroprotective potential of resveratrol through anti-oxidant and
anti-inflammatory mechanisms in rats. J Neural Transm (Vienna).
120:1217–1223. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Farzaei MH, Rahimi R, Nikfar S and
Abdollahi M: Effect of resveratrol on cognitive and memory
performance and mood: A meta-analysis of 225 patients. Pharmacol
Res. 128:338–344. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ulevitch RJ: Therapeutics targeting the
innate immune system. Nat Rev Immunol. 4:512–520. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Means TK, Golenbock DT and Fenton MJ: The
biology of Toll-like receptors. Cytokine Growth Factor Rev.
11:219–232. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Carmody RJ and Chen YH: Nuclear
factor-kappaB: Activation and regulation during toll-like receptor
signaling. Cell Mol Immunol. 4:31–41. 2007.PubMed/NCBI
|
|
29
|
Tu XK, Yang WZ, Chen JP, Chen Y, Ouyang
LQ, Xu YC and Shi SS: Curcumin inhibits TLR2/4-NF-κB signaling
pathway and attenuates brain damage in permanent focal cerebral
ischemia in rats. Inflammation. 37:1544–1551. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xiang HF, Cao DH, Yang YQ, Wang HQ, Zhu
LJ, Ruan BH, Du J and Wang MC: Isoflurane protects against injury
caused by deprivation of oxygen and glucose in microglia through
regulation of the Toll-like receptor 4 pathway. J Mol Neurosci.
54:664–670. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao Y, Patzer A, Herdegen T, Gohlke P and
Culman J: Activation of cerebral peroxisome proliferator-activated
receptors gamma promotes neuroprotection by attenuation of neuronal
cyclooxygenase-2 overexpression after focal cerebral ischemia in
rats. FASEB J. 20:1162–1175. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Candelario-Jalil E, González-Falcón A,
Garcia-Cabrera M, León OS and Fiebich BL: Wide therapeutic time
window for nimesulide neuroprotection in a model of transient focal
cerebral ischemia in the rat. Brain Res. 1007:98–108. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wei H, Wang S, Zhen L, Yang Q, Wu Z, Lei
X, Lv J, Xiong L and Xue R: Resveratrol attenuates the blood-brain
barrier dysfunction by regulation of the MMP-9/TIMP-1 balance after
cerebral ischemia reperfusion in rats. J Mol Neurosci. 55:872–879.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang L, Li Z, Zhang X, Wang S, Zhu C, Miao
J, Chen L, Cui L and Qiao H: Protective effect of shikonin in
experimental ischemic stroke: Attenuated TLR4, p-p38MAPK, NF-κB,
TNF-α and MMP-9 expression, up-regulated claudin-5 expression,
ameliorated BBB permeability. Neurochem Res. 39:97–106. 2014.
View Article : Google Scholar : PubMed/NCBI
|
